Figure 2. Symptom Severity among Participants by Age and Gender.
Comparison of endorsed symptom severity following dose 1 and dose 2 of SARS-CoV-2 vaccine by age groups (left) and gender (right).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.